Literature DB >> 3615876

Hemophilic arthropathy: assessment with MR imaging.

B S Yulish, J M Lieberman, S E Strandjord, P J Bryan, G P Mulopulos, M T Modic.   

Abstract

Fifteen patients with hemophilia, 14 of whom had hemophilic arthropathy, were examined with magnetic resonance (MR) imaging to determine if it could be used to assess hemophilic arthropathy, especially synovial hypertrophy and the status of the articular cartilage. Thirty-five joints of the appendicular skeleton were imaged. Four joints in two patients were clinically normal. Synovial hypertrophy was detected in 28 joints and appeared as areas of low to intermediate signal intensity on T1- and T2-weighted images, with foci of increased signal intensity on T2-weighted images (presumed to be due to areas of fluid or inflammation) in 16 joints. Abnormal articular cartilage was demonstrated in 26 joints; bone lesions, fluid collections, and joint space narrowing could also be seen. MR imaging appears to be useful in depicting the components of hemophilic arthropathy.

Entities:  

Mesh:

Year:  1987        PMID: 3615876     DOI: 10.1148/radiology.164.3.3615876

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  4 in total

1.  Case report 739: Tuberculous arthritis of knee.

Authors:  E Schultz; I Richterman; H D Dorfman
Journal:  Skeletal Radiol       Date:  1992       Impact factor: 2.199

2.  Case report 661. Hemophiliac bleed into a separate suprapatellar pouch (due to persistent plica).

Authors:  S J Armstrong; I Watt
Journal:  Skeletal Radiol       Date:  1991       Impact factor: 2.199

3.  Applications of magnetization transfer contrast in the musculoskeletal system in children.

Authors:  M Haliloglu; M D Cohen
Journal:  Pediatr Radiol       Date:  1996-12

Review 4.  Magnetic resonance imaging of the knee: current status, new directions.

Authors:  P L Munk; C A Helms; H K Genant; R G Holt
Journal:  Skeletal Radiol       Date:  1989       Impact factor: 2.199

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.